John Wiley & Sons - deal valued at ~7x adj EBITDA; expected accretive to adj EPS in year one

John Wiley & Sons, Inc. (NYSE: WLY) has announced a strategic acquisition expected to be accretive to adjusted earnings per share (EPS) in the first year, with a valuation multiple of approximately 7x adjusted EBITDA. The transaction aligns with the company’s ongoing focus on enhancing shareholder value through disciplined capital allocation and strategic growth initiatives. Wiley’s recent financial performance has been driven by research growth, AI licensing, and cost-reduction measures, contributing to strong fiscal results in 2025. The acquisition is expected to leverage Wiley’s existing digital and services infrastructure, which already generates 83% of its revenue.

According to industry standards, the accretion or dilution of an acquisition is often determined by comparing the weighted cost of the acquisition to the seller’s yield. In this case, the valuation suggests that the seller’s yield exceeds Wiley’s cost of capital, supporting the expectation of EPS accretion. However, as noted by McKinsey, while EPS accretion is often a focus for investors and boards, not necessarily a strong indicator of long-term value creation. The success of the deal will depend on effective integration and the realization of synergies beyond the initial financial metrics.